Filing Details
- Accession Number:
- 0001127602-11-007664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-25 15:54:37
- Reporting Period:
- 2011-02-23
- Filing Date:
- 2011-02-25
- Accepted Time:
- 2011-02-25 15:54:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1504983 | E. Robert Gagnon | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Chief Acct Officer Vp & Contr | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-23 | 815 | $0.00 | 11,352 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-02-23 | 191 | $0.00 | 11,543 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-23 | 259 | $66.76 | 11,284 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2011-02-23 | 61 | $66.76 | 11,223 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2011-02-24 | 1,054 | $49.65 | 12,277 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-24 | 1,054 | $66.99 | 11,223 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2011-02-23 | 815 | $0.00 | 815 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2011-02-23 | 191 | $0.00 | 191 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2011-02-23 | 217 | $0.00 | 0 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-02-24 | 1,054 | $0.00 | 1,054 | $49.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,077 | 2014-02-23 | No | 4 | M | Direct | |
| 3,886 | 2014-02-23 | No | 4 | M | Direct | |
| 3,669 | 2014-02-23 | No | 4 | J | Direct | |
| 2,108 | 2019-02-24 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $66.81 (low) and $67.23 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- There is no conversion or exercise price for this stock unit.
- The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
- The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.
Billionaire Hedge Funds
